Oct 18, 2017 | Compliance, Legal, and Malpractice, Digital Pathology, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing
The Joint Commission opposed the Medicare proposal, and patient advocate groups say rescinding it is a setback for hospital transparency Powerful interests arrayed against greater transparency in the performance of hospitals, physicians, and medical laboratories have stopped a proposed Medicare program that would have allowed the public to see the results of hospital inspections. Stopped in its tracks was an effort by the Centers for Medicare and Medicaid Services (CMS) to make hospital...
Sep 13, 2017 | Coding, Billing, and Collections, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing
While multiple studies show reference pricing is an effective approach to reduce the cost of testing and procedures, medical laboratories and consumers alike must continue to focus on quality to ensure positive outcomes The Dark Report in its September 2016 issue highlighted how reference pricing is positioned to become one of the biggest contributors to price erosion medical laboratories and pathology groups have faced in more than a decade. The issue featured details of a 2016 study...
Apr 1, 2011 | Laboratory News, Laboratory Pathology
That’s not news to pathologists, who often see how physicians mis-order or mis-interpret clinical laboratory tests Each month, one out of seven Medicare patients is injured or killed by their healthcare providers. These medical errors cost taxpayers hundreds of millions of dollars each year. And, that doesn’t even include the cost of follow-up care for the injured patients who survive. Those and other conclusions are part of a recently released study by the Department of Health and Human...
Apr 14, 2010 | Laboratory Management and Operations, Laboratory Pathology, Managed Care Contracts & Payer Reimbursement
In the long term, quality measures should elevate recognition of the value of clinical pathology testing Healthcare quality measures continue to increase, both in numbers and in sophistication. These quality measures offer consumers, insurers, employers, and government health agencies some information about the relative value of clinical services. But the holy grail of quality measures—outcomes data and cost data that adequately reflect patient complexity and environment—is still elusive, say...
